Health And Human Services, Department Of- Administration For Strategic Preparedness And Response- Barda - Aspr / Daappo / Barda Dcma
Advance the development of SCY- 247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula -